Skip to content

Celcuity CELC Common Stock

Common Stock at other companies

Eli Lilly logo
Eli LillyLLY
$590M-0.4%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
500M+253,707%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$171K+50.0%
Tango Therapeutics logo
Tango TherapeuticsTNGX
400M+100%
CG Oncology logo
CG OncologyCGON
$9K+12.5%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$3.12M+14.5%

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.28B+1,370%
Enterprise value$4.27B+1,086%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's common stock?
Celcuity (CELC) reported common stock of 95M in Q1 2026.
How has Celcuity's common stock changed year-over-year?
Celcuity's common stock decreased by 0.0% year-over-year, from 95M to 95M.
What is the long-term trend for Celcuity's common stock?
Over 5 years (2020 to 2025), Celcuity's common stock has grown at a 30.6% compound annual growth rate (CAGR), from 25M to 95M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).